ContraVir
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ContraVir and buy or sell other stocks, options, and ETFs commission-free!About CTRV
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
CEORobert T. Foster, PhD
CEORobert T. Foster, PhD
Employees—
Employees—
HeadquartersEdison, New Jersey
HeadquartersEdison, New Jersey
Founded2013
Founded2013
Employees—
Employees—
CTRV Key Statistics
Market cap115.86M
Market cap115.86M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume845.95K
Average volume845.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.85
52 Week high$3.85
52 Week low$1.36
52 Week low$1.36